The Antacids Market is projected to grow from USD 6.8 billion in 2025 to USD 10.2 billion by 2035, with a compound annual growth rate (CAGR) of 4.5%. This growth is driven by the increasing prevalence of gastroesophageal reflux disease (GERD) and digestive disorders, fueled by changing lifestyles and rising demand for over-the-counter (OTC) medications. The report provides actionable insights...